Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

13.3%

2 terminated out of 15 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed with results

Key Signals

6 with results86% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (13)
P 4 (1)

Trial Status

Completed12
Terminated2
Active Not Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
Showing all 15 trials

Research Network

Activity Timeline